2 minute read

The Children of the Stars

¡…And we are back!

In its written version is one more chapter of this incredible project, Clinical Research Insider. They have been difficult moments after the pandemic, where we have had to make forceful decisions to continue the Journal and the CLIR Congress, both of these are great projects. Pandemics, in addition to bringing adversity and deaths, many of them from people close to us, also get opportunities in a myriad of areas, from scientific advancement to the opening of new businesses or modifications in the trajectory of humanity. Pandemics, whether induced (as many believe, as they appear precisely every 100 years) or generated by variables within nature, have marked the course of humanity since their inception.

As far as we are concerned, science was marked by the accelerated development of multiple vaccines and various drugs with potential efficacy against SARS-CoV-2. Humanity understood the importance of developing highly specialized medicines, whether generated by living organisms

or in the laboratory, against present and future diseases. It was a moment that will not be repeated; the pandemic catalyzed for collective human consciousness to understand the capacities and limitations of human knowledge.

Research and science will accompany humanity forever, and they will be better understood and applied. That is why CLIR continues to strive in the part that corresponds to it, the scientific dissemination among all who want to learn more about this fascinating world.

We are called to survival because it has been shown that we can develop solutions to immediate problems through our wellknown scientific method, supported by the deductive or inductive analyses of our way of perceiving the universe. These are potent tools that will help us conquer the Cosmos!

The future is promising and very challenging! We will continue to be part of this great struggle for universal knowledge. The future awaits us on Earth as well as in the stars.

Marco Cid

CEO DROX Health Science – CLIR General Manager

Chemist-pharmacist Biologist from La Salle University, MBA from ITESO, postgraduate degree in Clinical Research from York College and Senior Management from IPADE InnovAD Program. Expert in drug research and development; entrepreneur, founder of several for-profit and non profit associations and developer of a private equity investment company.

Chemist-pharmacist Biologist from La Salle University, MBA from ITESO, postgraduate degree in Clinical Research from York College and Senior Management from IPADE InnovAD Program. Expert in drug research and development; entrepreneur, founder of several for-profit and non profit associations and developer of a private equity investment company.